1101 K Street NW Suite 400
Washington, DC 20005
Contact Information
Who We Are
The Global Alzheimer’s Platform Foundation (GAP) is a patient-centric, non-profit organization dedicated to speeding the delivery of innovative therapies to those afflicted with Alzheimer’s by reducing the time and cost of Alzheimer’s disease (AD) clinical trials.
GAP works with international organizations that share our goals for clinical trial innovation. GAP regularly engages with global partners to coordinate efforts, share information, and maintain open dialogue with initiatives under development in a number of countries and continents. These include:
- European Prevention of Alzheimer’s Dementia Consortium (EPAD)
- Canadian Consortium on Neurodegeneration in Aging (CCNA)
GAP-Net is a network of over 80 clinical trial sites across North America, which benefit from sharing knowledge and experience in order to effectively and efficiently work toward research progress in neurodegenerative conditions.